RECRUITINGPhase 2INTERVENTIONAL
Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder
Repetitive Transcranial Magnetic Stimulation to Promote Helpful Self-regulatory Behaviour in Children and Youth With Autism Spectrum Disorder
About This Trial
This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.
Who May Be Eligible (Plain English)
Who May Qualify:
- Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges
- Able to participate in rTMS
Who Should NOT Join This Trial:
- Children with autism spectrum disorder but no co-morbid self-regulation disorders.
- Children with contraindications to TMS (history of seizures, family history of seizures, metal implants)
- Co-existing neurological conditions (epilepsy, stroke, etc.)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges
* Able to participate in rTMS
Exclusion Criteria:
* Children with autism spectrum disorder but no co-morbid self-regulation disorders.
* Children with contraindications to TMS (history of seizures, family history of seizures, metal implants)
* Co-existing neurological conditions (epilepsy, stroke, etc.)
Treatments Being Tested
DEVICE
repetitive transcranial magnetic stimulation (rTMS)
30 minutes rTMS session 5 days/week for 3 weeks.
OTHER
Sham stimulation
30 minutes sham stimulation 5 days/week for 3 weeks.
Locations (1)
Bloorivew Research Institute
Toronto, Ontario, Canada